ZENG Jieming, M.D., Ph.D.

Dr. ZENG Jieming M.D., Ph.D. is a translational scientist with over two decades of benchwork experience, first author of 11 original research articles, scientific founder of CytoMed Therapeutics Limited, and inventor of both CytoMed’s CAR-γδ T cell and iPSC-γδ NKT cell technologies. He is now dedicated to translating these proprietary technologies into cell therapies for cancer treatment.